GoodRx Holdings' ROCE trend is concerning. Despite reinvestment in its business, shrinking returns and a significant stock price drop hint at a lack of multi-bagger potential.
RECAP US Stocks Retreat After Rallying in 2023 US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated. A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The$納斯達克綜合指數(.IXIC.US)$fell 1.6% to close at 14,765.94, its biggest daily decline since October. The$標普500指數(.SPX.US)$slipped 0...
Concern arises over GoodRx Holdings' high P/S ratio as future revenue projections seem insufficient to maintain positive evaluation. Unless significant revenue improvements occur, high P/S values likely unsustainable.
$GoodRx(GDRX.US)$fell Tuesday after raising 13% last week. The drop followed$西維斯健康(CVS.US)$investor day. The firm relased 2024 revenue guidance Tuesday morning, announcing a competitive prescription drug product called CostVantage, and a second program called TrueCost.
Stock is near 52 week low. large block purchases are being made on this dip still might have room to be lower. going to take position on the stock due to revenue and brand name. if there is any kind of recession in the near future the stock will be back up to its high due to individuals looking for the best options to pay for their prescriptions. good luck investing 😸
GoodRx's diminishing returns, despite reinvestment, is disheartening. Its sharp stock price drop could indicate investor anticipation of worsening company fundamentals, suggesting other investment options may be more promising.
Pre-Market Stock Movers Gapping up $Adobe(ADBE.US)$ (The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.) $雪佛龍(CVX.US)$ (Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.) $迪士尼(DIS.US)$ (T...
GoodRx股票討論區
📊⚡️📊
US Stocks Retreat After Rallying in 2023
US stocks pulled back on the first trading day of the year, locking gains posted in 2023, as the Magnificent Seven stocks retreated.
A Bloomberg gauge of the seven stocks declined 1.7%, weighing on the S&P 500 and the Nasdaq that are heavily weighted to the tech giants. The $納斯達克綜合指數(.IXIC.US)$ fell 1.6% to close at 14,765.94, its biggest daily decline since October. The $標普500指數(.SPX.US)$ slipped 0...
good luck investing 😸
值得注意的是上市當年營業利潤的2.76億巨虧主要來自管理費用暴增至4.6億,從第二年降回1.55億可以知道上市爲管理層個人帶來了多少利潤,儘管公司仍在巨虧。
2023上半年營收下滑了5.4%,靠縮減營業費用營業利潤提升到了0.3億,靠所得稅返還淨利潤達到了0.55億。
目前市盈率TTM278,綜合來看沒有投資價值。
Gapping up
$Adobe(ADBE.US)$
(The stock gained 2.4% before the bell after Morgan Stanley upgraded shares to overweight from equal weight and boosted its price target, citing artificial intelligence tailwinds.)
$雪佛龍(CVX.US)$
(Shares rose 1.6% after Goldman Sachs upgraded Chevron to buy from neutral and hiked its price target. Analysts said the oil giant is due for a breakout.)
$迪士尼(DIS.US)$
(T...
暫無評論